CRSP Stock Forecast Chart
CRSP Stock Forecast 2026 – Price Prediction, Target & Outlook
CRISPR Therapeutics AG (CRSP) stock forecast for 2026 indicates a wide range of potential outcomes based on analyst targets and model-driven predictions. As of July 2026, CRSP stock shows a dynamic price pattern in the short term, with price targets reflecting potential future volatility across bull, base, and bear scenarios over the next 12 months.
CRSP Bull Case Price Target (2027)
In a bullish scenario, CRSP stock could reach this maximum projection over the next 12 months, driven by upside momentum and outperforming technical indicators.
CRSP Base Forecast (2027)
The base case model predicts this median target, assuming CRSP maintains steady growth, consistent volume profiles, and normalized market conditions.
CRSP Bear Case Price Target (2027)
In a broader market downturn or bearish correction, CRSP shares could potentially trace back to this support level over the forecast horizon.
CRISPR Therapeutics AG Analyst Consensus & Target Price
Wall Street sentiment and price target analysis for CRSP
Consensus based on 21 analysts
High conviction buy - significant upside potential
Price Target Analysis
Target Range: $44.00 - $291.00
Current vs Mean Target: +74.8%
Analyst Coverage: 21 firms tracking
Key Considerations
• Target prices reflect 12-month outlook
• Based on fundamental analysis and DCF models
• Consider market volatility in timing decisions
CRSP stock Price Projections & Forecast Models
Data-driven price predictions based on technical analysis and analyst consensus for CRSP
Model-Based Predictions
Analyst Consensus
Model Methodology & Confidence
Technical Indicators:
- • Moving averages (SMA 20, 50, 200)
- • RSI and momentum oscillators
- • Support/resistance levels
- • Volume-price analysis
Fundamental Factors:
- • Earnings growth projections
- • Revenue trend analysis
- • Valuation multiple normalization
- • Sector performance correlation
Scenario Analysis Chart
CRISPR Therapeutics AG (CRSP) Detailed Price Forecast
Algorithmic projections for monthly price bands and momentum signals
According to current predictive modeling and historical volatility analysis, the company is projected to fluctuate between a potential low of $43.79 and a high of $146.15 over the forecast horizon. These estimates blend near-term technical momentum with fundamental analyst consensus targets.
| Period | Min Price | Avg Price | Max Price | Potential ROI | Signal |
|---|---|---|---|---|---|
| Aug 2026 | 43.91 | 51.78 | 59.65 | +8.4% | Buy |
| Sep 2026 | 43.79 | 55.77 | 67.76 | +16.7% | Buy |
| Oct 2026 | 44.04 | 59.77 | 75.50 | +25.1% | Buy |
| Nov 2026 | 44.39 | 63.77 | 83.15 | +33.5% | Buy |
| Dec 2026 | 44.74 | 67.77 | 90.79 | +41.8% | Buy |
| Jan 2027 | 45.05 | 71.76 | 98.48 | +50.2% | Buy |
| Feb 2027 | 45.30 | 75.76 | 106.22 | +58.6% | Buy |
| Mar 2027 | 45.47 | 79.76 | 114.04 | +66.9% | Buy |
| Apr 2027 | 45.57 | 83.76 | 121.94 | +75.3% | Buy |
| May 2027 | 45.58 | 87.75 | 129.92 | +83.7% | Buy |
| Jun 2027 | 45.51 | 91.75 | 137.99 | +92.0% | Buy |
| Jul 2027 | 45.34 | 95.75 | 146.15 | +100.4% | Buy |
Source methodology: Model forecasts are independent estimates blending technical signals with analyst consensus data. Actual market prices are subject to volatility and macroeconomic factors. All projections are for informational purposes only.